Ambrisentan (Letairis®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS AMBRISENTAN?

First Page		Document Content
Date: 2013-12-03 14:16:08 Pyrimidines Sulfonamides Ambrisentan Ethers Bosentan Endothelin receptor antagonist Pulmonary hypertension Endothelin Methadone Chemistry Organic chemistry Orphan drugs		Ambrisentan (Letairis®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS AMBRISENTAN? Add to Reading List Source URL: www.phassociation.org Download Document from Source Website File Size: 226,45 KB Share Document on Facebook

	Conference: 14th International Conference on Endothelin: Physiology, Pathophysiology and Therapeutics E 14 DocID: 1gPGn - View Document
	Endothelin-1 induces the transactivation of... [J Mol Med (Berldi 1 http://www.ncbi.nlm.nih.gov/pubmed?term=Endothelin-1 induces the tr... DocID: 1b5yP - View Document
	ORIGINAL ARTICLE Cardiology Journal 2009, Vol. 16, No. 4, pp. 348–354 Copyright © 2009 Via Medica ISSN 1897–5593 DocID: 1a4LY - View Document
	Clinical Commissioning Policy: Clinical Commissioning Policy: National policy for targeted DocID: 18zFu - View Document
	Kwartaalbericht 4e kwartaalNovember 2005 Contents DocID: 15SVk - View Document